Member Info for ratcliffewriter

Here you go again - I said he 'expressed an opinion that it COULD be.' I think you'll find his post yesterday morning was in response to your apparent insistence that he had categorically labelled the trades as by Vulpes. Anyway, perhaps you would like to contribute something about the possible progress of Scancell's products in trials, or what other news may be forthcoming rather than misquoting C7 and strangely now putting a slant on my own posts. Awfully sorry if you aren't a duplicated Aimbig - you just post and react in an incredibly similar and consistent way and I am not the only long term follower of the company who is inclined to this thought. So, if we're all done there, back to Scancell maybe...?

Joking aside, I think it needs pointing out that C7's posts expressed an opinion that it COULD be a Vulpes buy, based I suspect on the fact that the buys shown look very similar to their previous buys the two most recent being in November, when on consecutive days they announced 100k and then 200k shares bought by Vulpes Life Science Fund. I now those buys were at 19p, not 21p, but hen again that is a great deal higher than their placing buys so maybe they still see value coming in the share price. I presume the rest of do or we wouldn't be here still.
I don't think C7 ever did more than express a perfectly reasonable belief that it COULD be Vulpes, and I think made plain some hope that it MIGHT. So he is perfectly entitled to express that opinion and hope, not have it thrown back at him misquoted as a firm statement, which it never was. I remember the trolls of yore who at the sight of a sell of any size would state categorically 'oooh it's forward selling, placing coming' or the wonderful quote many may remember that 'somebody knows something' - now those lines were stated as Gospel but were patently lies and fantasy, yet didn't get the sustained barracking that AimB124 has levelled at C7. Pretty well all of those posters ended up banned anyway - only those with a few spare duplicate identities have the ability to remain I suspect.
The fact is that we are just awaiting the interims for definite, and Covidity/Moditope news probably. They say no news is good news and I hope (please note - hope - not categorical, just a hope - saves certain folk a lot of keyboard bashing) that the lack of further news from South Africa indicates (note - indicates, not proves) that there have been at the very least no adverse effects from the P1 Covidity trial. I hope (you get the idea) that there may be further news on early efficacy indications, and the trial moves on to London and into P2 all being well. I also hope that something moves on with Moditope. There is also the possibility of news on the combination trial of SCIB1 - after all the first patient was dosed a while ago, and they don't RNS beyond first patient and subsequent dosing, so perhaps there may even be developments there. But until then, it gets a bit quiet. The benefit of quieter times is that it gives more opportunity to speculate, or for some to stake build- which may or may not be happening at Vulpes, but speculating it doesn't warrant post after post of apparently deliberate misquoting and hounding.

Aibig is up and on the floor. https://youtu.be/E1o3cbLYoIY

Sad that AB's underlying hatred of C7 is so conspicuous as to cloud any potential use in that post.

That's a rather fatuous reply from AB. If we did the same over a longer period you could say that nothing ever happens as buys eventually balance sells. Ultimately a fairly poor attempt at trivialising a six digit buy.

Might be worth chucking a couple of bob into that company then...

Certainly are some very familiar words and phrases in there. Watching and waiting....

I don't intend to be drawn into this, but knowing how keen TF is on balance, and to this end he is often keen to copy and paste from the 'other side', so to that end it may be worth quoting part of ee's post to TF in relation to tf's submissions - 'Unfortunately your anti-Tory bigotry is preventing you from taking a rounded view of the facts.'

Whatever the sp does for now, it's a huge step up from being in an article listing a number of small bios, to being in a national newspaper as one of seven to watch for this year from the entire range of businesses available.

Moving up nicely.

If that's the start of a new PR offensive then that's great. If it's spontaneously discovered by the Grauniad then even better really. Every well heeled champagne socialist in London will be aware of Scancell.

Hi C7 - I look at numbers of twitter followers on and off, but have no idea how to use that setup. It strikes me as a sort of barometer of interest in a way - maybe not pivotal but it is always interesting to see what causes a step up in the numbers, for example the flurry of media exposure last year bumped the numbers up if I remember right, although twitter could vanish overnight and imo it would make no difference at all to Scancell's direction and progress, it would more likely just lead to a lot of trout-pouted nonebrities losing a platform to talk bolleaux. But maybe I'm not as 'social media savvy' as others.
As I say, it's a sideline to watch while waiting.
Happy New Year all.

Back to 1009 now. That's put an end to the maths debating for tonight.

Just reached 1010. Not particularly significant, but a nice number. In binary it would be 1111110010.
Maybe one day.....

Just gone to 1008 followers.

42 is the answer to the ultimate question of life, the universe and everything. Sounds a bit like Moditope....
Another source of answers to difficult questions is The Godfather. 'Leave the gun, take the cannoli.'

Whether you call it 'free shares' or anything else, the fact remains that CC did sell a large number of shares in the 30s which would recoup their initial investment costs, something any fund manager should be reasonably happy with. It's anyone's guess, but as I say - time will tell. Conjecture can be fun, but whether it is the start of a new chapter or a damp squib I'm not too concerned.

HH - CC is least likely imo, for two main reasons - firstly they sold a sizeable proportion of their holding a few years ago above 30p and are now more or less on 'free shares' I believe, and secondly given that they have stayed invested through thick and thin (and a fair few dilutions), it would seem incredibly odd to sell when the company is (once more...) at a pivotal point in its development. But hey, anything is possible - time will tell.

That would make sense imo C7 - scenario of Redmile gets 8 million quid for 5 percent which gives a healthy initial return for their investment (20 percent of their total outlay approximately) and if sold to a significant further investor it boosts the share value and more usefully the profile of the company and its prospects. (Other theories are available)
I also feel that if someone had dumped 5 percent of the shares in issue, then the SP would have gone down faster than something quite unprintable here, so feeling intriguedly optimistic, even if 'intriguedly' isn't a proper word.

Or DE sold most or all of them last year, depending in which rumour mill you believe.